Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
11.70
+0.07 (0.60%)
Mar 9, 2026, 3:26 PM EDT - Market open
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $204.46 million as of March 9, 2026. Its market cap has increased by 109.67% in one year.
Market Cap
204.46M
Enterprise Value
198.90M
1-Year Change
109.67%
Ranking
Category
Stock Price
$11.70
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $204.46M, a decrease of -34.51%. That is a compound annual growth rate of -14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 203.23M | 46.11% |
| Dec 31, 2025 | 139.10M | 153.09% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 216.84M |
| Humacyte | 214.23M |
| Cibus | 213.48M |
| Protalix BioTherapeutics | 210.70M |
| ProMIS Neurosciences | 209.84M |
| Arcturus Therapeutics Holdings | 202.09M |
| Acumen Pharmaceuticals | 200.50M |
| Galectin Therapeutics | 199.87M |